Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · Real-Time Price · USD
2.620
-0.160 (-5.76%)
Mar 6, 2026, 4:00 PM EST - Market closed

Protalix BioTherapeutics Market Cap

Protalix BioTherapeutics has a market cap or net worth of $210.70 million as of March 6, 2026. Its market cap has increased by 14.45% in one year.

Market Cap
210.70M
Enterprise Value
189.51M
1-Year Change
14.45%
Ranking
Category
Stock Price
$2.62

Market Cap Chart

Since December 1, 1998, Protalix BioTherapeutics's market cap has increased from $11.80M to $210.70M, an increase of 1,685.62%. That is a compound annual growth rate of 11.15%.

History

DateMarket Cap% Change
Mar 5, 2026223.60M54.42%
Dec 31, 2025144.80M4.62%
Dec 31, 2024138.40M6.54%
Dec 29, 2023129.90M87.18%
Dec 30, 202269.40M83.11%
Dec 31, 202137.90M-68.68%
Dec 31, 2020121.00M148.46%
Dec 31, 201948.70M5.64%
Dec 31, 201846.10M-50.11%
Dec 29, 201792.40M107.64%
Dec 30, 201644.50M-56.29%
Dec 31, 2015101.80M-40.95%
Dec 31, 2014172.40M-52.64%
Dec 31, 2013364.00M-24.96%
Dec 31, 2012485.10M14.93%
Dec 30, 2011422.10M-47.92%
Dec 31, 2010810.50M58.46%
Dec 31, 2009511.50M266.14%
Dec 31, 2008139.70M-45.71%
Dec 31, 2007257.30M2,552.58%
Dec 29, 20069.70M-21.77%
Dec 30, 200512.40M1,671.43%
Dec 31, 2004700.00K-41.67%
Dec 31, 20031.20M300.00%
Dec 31, 2002300.00K-57.14%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Camp4 Therapeutics 238.13M
Achieve Life Sciences 234.23M
Canton Strategic Holdings 231.83M
Keros Therapeutics 230.89M
MediWound 223.62M
ProMIS Neurosciences 222.31M
Alector 220.17M
Sol-Gel Technologies 220.08M
Market Cap Rankings